ES2140398T3 - Produccion de factor xiii a por tecnologia genetica. - Google Patents

Produccion de factor xiii a por tecnologia genetica.

Info

Publication number
ES2140398T3
ES2140398T3 ES92105735T ES92105735T ES2140398T3 ES 2140398 T3 ES2140398 T3 ES 2140398T3 ES 92105735 T ES92105735 T ES 92105735T ES 92105735 T ES92105735 T ES 92105735T ES 2140398 T3 ES2140398 T3 ES 2140398T3
Authority
ES
Spain
Prior art keywords
production
factor xiii
genetic technology
new
transformed cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92105735T
Other languages
English (en)
Inventor
Ulrich Dr Grundmann
Egon Dr Amann
Gerd Dr Zettlmeissl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Application granted granted Critical
Publication of ES2140398T3 publication Critical patent/ES2140398T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1025—Acyltransferases (2.3)
    • C12N9/104—Aminoacyltransferases (2.3.2)
    • C12N9/1044—Protein-glutamine gamma-glutamyltransferase (2.3.2.13), i.e. transglutaminase or factor XIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/91045—Acyltransferases (2.3)
    • G01N2333/91074—Aminoacyltransferases (general) (2.3.2)
    • G01N2333/9108—Aminoacyltransferases (general) (2.3.2) with definite EC number (2.3.2.-)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/91045—Acyltransferases (2.3)
    • G01N2333/91074—Aminoacyltransferases (general) (2.3.2)
    • G01N2333/9108—Aminoacyltransferases (general) (2.3.2) with definite EC number (2.3.2.-)
    • G01N2333/91085—Transglutaminases; Factor XIIIq (2.3.2.13)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Food Science & Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

CON LA AYUDA DE UN BANCO-CDNA DE PLACENTA HUMANA Y SONDAS QUE HA SIDO CONSTRUIDO SEGUN LA SECUENCIA DE AMINOACIDOS DE FRAGMENTOS DE PEPTIDOS DEL FACTOR XIIIA, SE HA AISLADO EL CDNA QUE CODIFICA PARA EL FACTOR XIIIA. CON ESTE CDNA NO PUEDE OBTENERSE POR TECNICA GENETICA SOLO EL FACTOR XIIIA CON ALTA PUREZA, TAMBIEN PUEDEN HACERSE DIAGNOSTICOS QUE PERMITEN PUREZA, TAMBIEN PUEDEN HACERSE DIAGNOSTICOS QUE PERMITEN EL ANALISIS DE DEFECTOS DEL FACTOR XIIIA DE ORIGEN GENETICO. ADEMAS PUEDEN FABRICARSE ANTICUERPOS A BASE DE LA SECUENCIA DE AMINOACIDOS QUE SON APTOS PARA DIAGNOSTICOS O COLUMNAS DE ANTICUERPOS.
ES92105735T 1986-03-12 1987-03-06 Produccion de factor xiii a por tecnologia genetica. Expired - Lifetime ES2140398T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3608280 1986-03-12
DE19863621371 DE3621371A1 (de) 1986-03-12 1986-06-26 Gentechnische herstellung von faktor xiiia

Publications (1)

Publication Number Publication Date
ES2140398T3 true ES2140398T3 (es) 2000-03-01

Family

ID=25841904

Family Applications (2)

Application Number Title Priority Date Filing Date
ES92105735T Expired - Lifetime ES2140398T3 (es) 1986-03-12 1987-03-06 Produccion de factor xiii a por tecnologia genetica.
ES87103222T Expired - Lifetime ES2076926T3 (es) 1986-03-12 1987-03-06 Produccion por tecnologia genetica de factor xiiia.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES87103222T Expired - Lifetime ES2076926T3 (es) 1986-03-12 1987-03-06 Produccion por tecnologia genetica de factor xiiia.

Country Status (7)

Country Link
EP (2) EP0236978B1 (es)
JP (2) JPH0640825B2 (es)
AT (2) ATE124454T1 (es)
AU (1) AU605757B2 (es)
CA (1) CA1341516C (es)
DE (3) DE3621371A1 (es)
ES (2) ES2140398T3 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK175919B1 (da) * 1986-09-19 2005-06-27 Univ Washington Ekspression af biologisk aktiv faktor XIII
DE3808048A1 (de) * 1988-03-11 1989-09-21 Behringwerke Ag Verfahren zum affinitaetschromatografischen reinigen von faktor xiii
DE3819463A1 (de) * 1988-06-08 1989-12-14 Behringwerke Ag Expressionsvektoren zur herstellung unfusionierter proteine in mikroorganismen
US5204447A (en) * 1988-11-14 1993-04-20 Zymogenetics, Inc. Purification of factor xiii
US5612456A (en) * 1988-11-14 1997-03-18 Zymogenetics, Inc. Factor XIII compositions
DE3905674A1 (de) * 1989-02-24 1990-08-30 Bosch Gmbh Robert Leuchte insbesondere fuer kraftfahrzeuge
CS136091A3 (en) * 1990-05-10 1992-04-15 Zymo Genetics Agents for determining thrombi and their application
AU3428493A (en) * 1991-12-31 1993-07-28 Zymogenetics Inc. Novel human transglutaminases
GB9424823D0 (en) * 1994-12-08 1995-02-08 Univ Leeds Genetic basis of factor XIII activity
WO1996021025A1 (en) * 1994-12-30 1996-07-11 Zymogenetics, Inc. Bovine factor xiii
US6207877B1 (en) 1998-09-23 2001-03-27 Aventis Behring Gmbh Transgenic coagulation factor XIII defective animal and its use for testing wound healing and bleeding
EP1045026A1 (en) * 1999-04-16 2000-10-18 Aventis Behring Gesellschaft mit beschränkter Haftung A transgenic coagulation factor XIII defective animal and its use for testing wound healing and bleeding
DK0989184T3 (da) * 1998-09-23 2009-03-02 Csl Behring Gmbh Koagulationsfaktor XIII-defekt transgent dyr og dets anvendelse til test af sårheling og blödning
EP1434590B1 (en) 2001-10-09 2008-03-12 ZymoGenetics, Inc. Method for inhibiting the formation of seromas using factor xiii
EP1515142A1 (en) * 2003-09-12 2005-03-16 BioVisioN AG Mass spectrometry methods for direct phenotyping of factor XIIIA polymorphisms
US8461302B2 (en) 2004-11-23 2013-06-11 Zymogenetics, Inc. Purification of recombinant human factor XIII

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2916711A1 (de) * 1979-04-25 1980-11-06 Behringwerke Ag Blutgerinnungsfaktoren und verfahren zu ihrer herstellung
GB2125409B (en) * 1982-08-04 1985-11-13 Nat Res Dev Genetic engineering
DE3419581A1 (de) * 1984-05-25 1985-11-28 Behringwerke Ag, 3550 Marburg Verfahren zur gewinnung einer faktor xiii-praeparation sowie ihre verwendung
DK175919B1 (da) * 1986-09-19 2005-06-27 Univ Washington Ekspression af biologisk aktiv faktor XIII

Also Published As

Publication number Publication date
ATE124454T1 (de) 1995-07-15
DE3752298D1 (de) 1999-11-18
DE3621371A1 (de) 1987-09-17
EP0494702A2 (de) 1992-07-15
DE3751368D1 (de) 1995-08-03
ES2076926T3 (es) 1995-11-16
AU6989687A (en) 1987-09-17
EP0494702B1 (de) 1999-10-13
JPH05192141A (ja) 1993-08-03
EP0236978A3 (en) 1988-12-21
EP0236978A2 (de) 1987-09-16
JPH0761262B2 (ja) 1995-07-05
ATE185604T1 (de) 1999-10-15
JPH0640825B2 (ja) 1994-06-01
EP0494702A3 (en) 1992-11-19
AU605757B2 (en) 1991-01-24
EP0236978B1 (de) 1995-06-28
CA1341516C (en) 2006-11-28
JPS6339585A (ja) 1988-02-20

Similar Documents

Publication Publication Date Title
ES2076926T3 (es) Produccion por tecnologia genetica de factor xiiia.
ATE123295T1 (de) Rezeptor-proteine für humanen b-zellen stimulierenden faktor 2.
ATE172494T1 (de) Lymphokin-herstellung und -reinigung
MX428A (es) Region regulatoria para expresion de gen heterologa en levadura.
ATE105858T1 (de) Dna-moleküle, die für fmdh-kontrollabschnitte und strukturgene für ein protein mit fmdh-aktivität kodieren, sowie deren anwendung.
ATE138101T1 (de) Dna-fragment, das ein polypeptid mit nitrilhydrataseaktivität kodiert, dna-fragment enthaltende transformante und verfahren zur herstellung von amiden unter verwendung der transformante
DE3851289D1 (de) Verfahren zur Züchtung rekombinanter Zellen.
FI883082A0 (fi) Konstruering av syntetisk dna och dess anvaendning i syntes av stora polypeptider.
AU8110487A (en) DNA molecules coding for proteins targeted to plant cell walls
ATE152124T1 (de) Wachstumsfaktor aus parenchymalen lebenszellen, dafür kodierendes gen, verfahren zur herstellung dieses faktors und transformanten
ATE79403T1 (de) Herstellung von thrombin-inhibitoren.
DE3881023D1 (de) Proteine, expressionsvektoren, die fuer solche proteine kodierende dna enthalten und zellen, die solche expressionsvektoren enthalten.
EP0255320A3 (en) Production of proteins in myeloma cells
ATE102994T1 (de) Verfahren zur herstellung von proteinen.
GB2171703B (en) Expression-secretion vector for gene expression and protein secretion, recombinant dna including the vector, and method of producing proteins by use of the re
DE69329190D1 (de) Autotaxin : ein das selbständige zellbewegungsvermögen stimulierendes protein nützlich in der krebs-diagnostik und therapie
ATE88499T1 (de) Expressionsvektoren zur proteinsynthese sowie plasmidreplikons und sequenzkassetten, die zur herstellung solcher vektoren geeignet sind.
FI945877A0 (fi) Menetelmä proteiini C:n tuottamiseksi
DK260188D0 (da) Enzymproduktion
KR910016923A (ko) 트롬빈 결합성 물질의 제조법
ATE224913T1 (de) Prostaglandin-e-rezeptoren, deren dna und herstellung
KR860008282A (ko) 재조합 사람 레닌의 제조방법
ATA435083A (de) Das polypeptid interleukin-2 kodierendes gen, rekombinante, dieses gen enthaltende dna, diese rekombinante dna aufweisende zellinien und verfahren zur herstellung von interleukin-2 unter verwendung der genannten zellen
ATE276372T1 (de) Pichia methanolica glyceraldehyd-3-phosphat- dehydrogenase-1-promoter und -terminator
IT1186750B (it) Vettore di clonaggio,molecole di dna ricombinante,ceppi di bacillus subtilis trasformati con dette molecole e metodi per l'espressione di geni eterologhi e produzione e secrezione di proteine codificate da detti geni

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 494702

Country of ref document: ES